Brexpiprazole for agitation in clinically relevant patient subgroups: a post hoc analysis of efficacy and safety in patients with agitation associated with dementia due to Alzheimer’s disease

Curr Med Res Opin. 2025 Aug 23:1-16. doi: 10.1080/03007995.2025.2552278. Online ahead of print. ABSTRACT OBJECTIVE: To explore the efficacy and safety of brexpiprazole for the treatment of agitation symptoms in clinically relevant subgroups of patients with dementia...

Are they looking for support? Mental health and trauma awareness as predictors of mental health help-seeking behaviour among young adults and adolescents in Bangladesh, Egypt, Ghana and the United Arab Emirates

BMC Public Health. 2025 Aug 22;25(1):2887. doi: 10.1186/s12889-025-24247-1. ABSTRACT BACKGROUND: Mental health is increasingly recognized worldwide as a significant public health challenge. However, progress in developing interventions to address mental health...